Literature DB >> 14766426

Wnt signaling in B and T lymphocytes.

Ya-Wei Qiang1, Stuart Rudikoff.   

Abstract

Wnt signaling has been shown to be critical for proper embryonic development as well as growth regulation of certain adult tissues. Defects in Wnt pathways have additionally been associated with a number of human cancers. However, it is only recently that a role for Wnts in the immune system has come to be appreciated. Wnts have now been shown to play significant roles in early stage development of both B and T lineage cells. Current studies suggest that proliferation and/or survival of these cells is associated with activation of the 'canonical' Wnt/beta-catenin pathway. Functional Wnt signaling appears to also occur in end stage B (plasma) cells where both the 'canonical' and the Wnt/RhoA pathways are activated. Herein, we review the current understanding of Wnt signaling in B and T cell development and the potential involvement of Wnt cascades in lymphoid neoplasia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14766426     DOI: 10.2741/1309

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  9 in total

1.  Rapid culling of the CD4+ T cell repertoire in the transition from effector to memory.

Authors:  Matthew A Williams; Eugene V Ravkov; Michael J Bevan
Journal:  Immunity       Date:  2008-03-20       Impact factor: 31.745

2.  Canonical Wnt signaling negatively regulates platelet function.

Authors:  Brian M Steele; Matthew T Harper; Iain C Macaulay; Craig N Morrell; Alita Perez-Tamayo; Martina Foy; Raymond Habas; Alastair W Poole; Desmond J Fitzgerald; Patricia B Maguire
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205

3.  Wnt signalling meets epigenetics.

Authors:  Frank J T Staal
Journal:  Stem Cell Investig       Date:  2016-08-12

4.  Transgenic expression of a canonical Wnt inhibitor, kallistatin, is associated with decreased circulating CD19+ B lymphocytes in the peripheral blood.

Authors:  Jeffrey D McBride; Xiaochen Liu; William L Berry; Ralf Janknecht; Rui Cheng; Kelu Zhou; Evangelos V Badiavas; Jian-Xing Ma
Journal:  Int J Hematol       Date:  2017-03-15       Impact factor: 2.490

5.  Characterization of Wnt/beta-catenin signalling in osteoclasts in multiple myeloma.

Authors:  Ya-Wei Qiang; Yu Chen; Nathan Brown; Bo Hu; Joshua Epstein; Bart Barlogie; John D Shaughnessy
Journal:  Br J Haematol       Date:  2009-11-24       Impact factor: 6.998

6.  Wnt3a signaling within bone inhibits multiple myeloma bone disease and tumor growth.

Authors:  Ya-Wei Qiang; John D Shaughnessy; Shmuel Yaccoby
Journal:  Blood       Date:  2008-03-14       Impact factor: 22.113

Review 7.  The canonical Wnt signaling pathway plays an important role in lymphopoiesis and hematopoiesis.

Authors:  Frank J T Staal; Jyoti M Sen
Journal:  Eur J Immunol       Date:  2008-07       Impact factor: 5.532

8.  Modulation of beta-catenin and E-cadherin interaction by Vpu increases human immunodeficiency virus type 1 particle release.

Authors:  Aneeza Salim; Lee Ratner
Journal:  J Virol       Date:  2008-02-06       Impact factor: 5.103

Review 9.  Wnt signaling in multiple myeloma: a central player in disease with therapeutic potential.

Authors:  Ingrid Spaan; Reinier A Raymakers; Anja van de Stolpe; Victor Peperzak
Journal:  J Hematol Oncol       Date:  2018-05-18       Impact factor: 17.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.